等待開盤 02-20 09:30:00 美东时间
-0.080
-0.32%
BRIEF-Cervomed’S Neflamapimod Elected For Inclusion In Uk Experts-Als Platform Feb 18 (Reuters) - CervoMed Inc CRVO.O : CERVOMED’S NEFLAMAPIMOD ELECTED FOR INCLUSION IN UK EXPERTS-ALS PLATFORM DESIGNED TO PRIORITIZE PROMISING TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS CERVOMED INC - FIRST ALS PATI
02-18 19:10
BRIEF-Paramount Skydance Says Warner Bros To Provide Company 7-Day “Waiver” For Negotiation Feb 17 (Reuters) - Paramount Skydance Corp PSKY.O : PARAMOUNT SKYDANCE - ACKNOWLEDGES ANNOUNCEMENT FROM WBD, ACTING WITH NETFLIX, HAVE DECIDED TO PROVIDE PARAMOUNT A 7-DAY “WAIVER” FOR NEGOTIATION PARAMOUNT S
02-18 03:50
BRIEF-Aimia Announces Dual Listing On Johannesburg Stock Exchange Feb 17 (Reuters) - Aimia Inc AIM.TO : AIMIA ANNOUNCES DUAL LISTING ON JOHANNESBURG STOCK EXCHANGE AIMIA INC - TO TRADE ON JSE UNDER SHARE CODE 'AII' AIMIA INC - MAINTAINS PRIMARY LISTING ON TSX, NO CAPITAL RAISE WITH ITS SECONDARY LIS
02-17 19:33
BRIEF-Teva And Sanofi’S Duvakitug Phase 2B Maintenance Data Demonstrated Efficacy In Ulcerative Colitis And Crohn’S Disease Feb 17 (Reuters) - Teva Pharmaceutical Industries Ltd TEVA.TA : TEVA AND SANOFI’S DUVAKITUG PHASE 2B MAINTENANCE DATA DEMONSTRATED CLINICALLY MEANINGFUL DURABLE EFFICACY IN ULC
02-17 19:24
BRIEF-Valero Houston, Texas Refinery Reports Maintenance Activities Feb 17 (Reuters) - VALERO ENERGY CORP VLO.N : REPORTS MAINTENANCE ACTIVITIES MAY REQUIRE USE OF SAFETY FLARE SYSTEM AT HOUSTON, TEXAS REFINERY SOURCE - COMMUNITY ALERT REFINERY CAPACITY: 205,000 BARRELS PER DAY (( Reuters.Briefs@tho
02-17 19:15
BRIEF-Sanofi Says Phase 2B Study Shows duvakitug Efficacious In Ulcerative Colitis, Crohn's Disease Feb 17 (Reuters) - Sanofi SA SASY.PA : SANOFI AND TEVA’S DUVAKITUG PHASE 2B MAINTENANCE DATA DEMONSTRATED CLINICALLY MEANINGFUL DURABLE EFFICACY IN ULCERATIVE COLITIS AND CROHN’S DISEASE DUVAKITUG WAS
02-17 19:09
Rithm Property Trust Q4 comprehensive income $2.5 mln, declares dividend Overview Real estate investment trust's Q4 GAAP comprehensive income was $2.5 mln, $0.33 per share Earnings available for distribution in Q4 were negative at $(0.5) mln Company paid a Q4 common dividend of $2.7 mln or $0.36 per
02-13 19:52
BRIEF-A.I.S. Resources’ Saint John Copper/Gold/Antimony Project Gets Tsxv Acceptance Feb 13 (Reuters) - A.I.S. Resources Limited AIS.V : A.I.S. RESOURCES’ SAINT JOHN COPPER/GOLD/ANTIMONY PROJECT GETS TSXV ACCEPTANCE Source text: ID:nGNX9YF8Np Further company coverage: AIS.V (( Reuters.Briefs@thomson
02-13 19:31
Sylvamo Q4 revenue beats on higher LatAm volumes Overview Paper company's Q4 revenue beat analyst expectations Adjusted EPS for Q4 beat analyst expectations Adjusted EBITDA for Q4 beat analyst expectations Outlook Sylvamo expects paper price increases in North America to begin realization in Q2 Comp
02-12 20:10
Core Natural Resources Q4 adjusted EBITDA misses estimates Overview U.S. coal producer's Q4 revenue totaled $1.042 bln, adjusted EBITDA missed analyst expectations Company reported a net loss of $79 mln in Q4 Resumed longwall mining at Leer South, completed transition at West Elk Outlook Core expect
02-12 20:02